|字體：小 中 大|
|Sundial Growers Inc. (SNDL, 0.735) is a cannabis company engaged in the production, distribution and sale of cannabis for the medical and adult-use market. The Company produces and markets premium cannabis for the adult-use market. In Sundial’s purpose-built indoor modular grow rooms, the Company produces consistent cannabis in individual and fully controlled room environments. The Company’s cannabis products are used as prescription medicines, and to enhance social, spiritual and recreational occasions. The Company sells Sundial Cannabis-branded dried flower cannabis products in a range of formats, such as pre-rolls, oils, capsules and sublingual.
Over the last six months, Sundial has raised net cash proceeds of $117 million through equity and equity linked issuances. The Company has 744 million common shares outstanding and an unrestricted cash balance of $85 million that has increased predominantly due to recent material warrant exercises, providing significant stability and financial flexibility to pursue growth and strategic opportunities.
"Sundials long-term viability is a prerequisite for the creation of shareholder value," said Sundials CFO, Jim Keough. "While the process of raising capital and converting debt into equity has placed near-term pressure on the price of our common shares, it has been essential to improving the companys financial strength, providing us with the resources and strategic flexibility to pursue a path to profitability."
Canadas Sundial Growers Clears C$73.2 Million Convertible Notes; Stock Jumps 35%.
Buy it at $0.735 or lower and sell it at $1.22 or higher(免責聲明：投資有風險，請謹慎評估，若決定購買，請自設停損）
法律聲明： 我目前持有以上的股票 (美西時間：03:41 AM 11-30-20)
|( 知識學習｜商業管理 )|